These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37451202)

  • 1. Long COVID prevalence and associated characteristics among a South Alabama population.
    Daniel CL; Fillingim S; James J; Bassler J; Lee A
    Public Health; 2023 Aug; 221():135-141. PubMed ID: 37451202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months' follow-up.
    Petersen MS; Kristiansen MF; Hanusson KD; Foldbo BM; Danielsen ME; Á Steig B; Gaini S; Strøm M; Weihe P
    Int J Infect Dis; 2022 Sep; 122():437-441. PubMed ID: 35753603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design.
    Malambo W; Chanda D; Besa L; Engamba D; Mwiinga L; Mwitumwa M; Matibula P; Naik N; Sivile S; Agolory S; Auld A; Mulenga L; Hines JZ; Fwoloshi S
    PLoS One; 2024; 19(7):e0306131. PubMed ID: 38954717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
    Desgranges F; Tadini E; Munting A; Regina J; Filippidis P; Viala B; Karachalias E; Suttels V; Haefliger D; Kampouri E; Van Singer M; Tschopp J; Rochat Stettler L; Schaad S; Brahier T; Hugli O; Mueller Y; Gouveia A; Opota O; Carron PN; Guery B; Papadimitriou-Olivgeris M; Boillat-Blanco N;
    J Gen Intern Med; 2022 Jun; 37(8):1943-1952. PubMed ID: 35319081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
    Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
    JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.
    Dennis A; Wamil M; Alberts J; Oben J; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Brady M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A;
    BMJ Open; 2021 Mar; 11(3):e048391. PubMed ID: 33785495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group.
    Cazé AB; Cerqueira-Silva T; Bomfim AP; de Souza GL; Azevedo AC; Brasil MQ; Santos NR; Khouri R; Dan J; Bandeira AC; Cavalcanti LP; Barral-Netto M; Barral A; Barbosa CG; Boaventura VS
    J Glob Health; 2023 May; 13():06015. PubMed ID: 37166260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Correlates of Long COVID Symptoms Among US Adults.
    Perlis RH; Santillana M; Ognyanova K; Safarpour A; Lunz Trujillo K; Simonson MD; Green J; Quintana A; Druckman J; Baum MA; Lazer D
    JAMA Netw Open; 2022 Oct; 5(10):e2238804. PubMed ID: 36301542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
    Steinbeis F; Thibeault C; Doellinger F; Ring RM; Mittermaier M; Ruwwe-Glösenkamp C; Alius F; Knape P; Meyer HJ; Lippert LJ; Helbig ET; Grund D; Temmesfeld-Wollbrück B; Suttorp N; Sander LE; Kurth F; Penzkofer T; Witzenrath M; Zoller T
    Respir Med; 2022 Jan; 191():106709. PubMed ID: 34871947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
    García-Abellán J; Padilla S; Fernández-González M; García JA; Agulló V; Andreo M; Ruiz S; Galiana A; Gutiérrez F; Masiá M
    J Clin Immunol; 2021 Oct; 41(7):1490-1501. PubMed ID: 34273064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
    Ghosn J; Bachelet D; Livrozet M; Cervantes-Gonzalez M; Poissy J; Goehringer F; Gandonniere CS; Maillet M; Bani-Sadr F; Martin-Blondel G; Tattevin P; Launay O; Surgers L; Dudoignon E; Liegeon G; Zucman D; Joseph C; Senneville E; Yelnik C; Roger PM; Faure K; Gousseff M; Cabié A; Duval X; Chirouze C; Laouénan C;
    Clin Microbiol Infect; 2023 Feb; 29(2):254.e7-254.e13. PubMed ID: 36191847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
    Ghosn J; Piroth L; Epaulard O; Le Turnier P; Mentré F; Bachelet D; Laouénan C;
    Clin Microbiol Infect; 2021 Jul; 27(7):1041.e1-1041.e4. PubMed ID: 34125067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.